Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.3 USD | +17.05% | -12.88% | -52.87% |
05-15 | Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating | MT |
05-14 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.87% | 114M | |
+7.87% | 219B | |
+11.83% | 192B | |
+18.87% | 142B | |
+30.03% | 111B | |
+1.63% | 65.32B | |
+14.15% | 52.45B | |
+2.68% | 49.8B | |
+6.60% | 43.43B | |
+1.85% | 35.95B |
- Stock Market
- Equities
- AKYA Stock
- News Akoya Biosciences, Inc.
- Morgan Stanley Adjusts Akoya Biosciences' Price Target to $19 from $20, Keeps Overweight Rating